Unknown

Dataset Information

0

Targeting the RhoGEF ?PIX/COOL-1 in Glioblastoma: Proof of Concept Studies.


ABSTRACT: Glioblastoma (GBM), a highly invasive and vascular malignancy is shown to rapidly develop resistance and evolve to a more invasive phenotype following bevacizumab (Bev) therapy. Rho Guanine Nucleotide Exchange Factor proteins (RhoGEFs) are mediators of key components in Bev resistance pathways, GBM and Bev-induced invasion. To identify GEFs with enhanced mRNA expression in the leading edge of GBM tumours, a cohort of GEFs was assessed using a clinical dataset. The GEF ?Pix/COOL-1 was identified, and the functional effect of gene depletion assessed using 3D-boyden chamber, proliferation, and colony formation assays in GBM cells. Anti-angiogenic effects were assessed in endothelial cells using tube formation and wound healing assays. In vivo effects of ?Pix/COOL-1-siRNA delivered via RGD-Nanoparticle in combination with Bev was studied in an invasive model of GBM. We found that siRNA-mediated knockdown of ?Pix/COOL-1 in vitro decreased cell invasion, proliferation and increased apoptosis in GBM cell lines. Moreover ?Pix/COOL-1 mediated endothelial cell migration in vitro. Mice treated with ?Pix/COOL-1 siRNA-loaded RGD-Nanoparticle and Bev demonstrated a trend towards improved median survival compared with Bev monotherapy. Our hypothesis generating study suggests that the RhoGEF ?Pix/COOL-1 may represent a target of vulnerability in GBM, in particular to improve Bev efficacy.

SUBMITTER: Connor K 

PROVIDER: S-EPMC7761123 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Glioblastoma (GBM), a highly invasive and vascular malignancy is shown to rapidly develop resistance and evolve to a more invasive phenotype following bevacizumab (Bev) therapy. Rho Guanine Nucleotide Exchange Factor proteins (RhoGEFs) are mediators of key components in Bev resistance pathways, GBM and Bev-induced invasion. To identify GEFs with enhanced mRNA expression in the leading edge of GBM tumours, a cohort of GEFs was assessed using a clinical dataset. The GEF βPix/COOL-1 was identified,  ...[more]

Similar Datasets

2018-12-21 | GSE109514 | GEO
| S-EPMC3874057 | biostudies-other
| S-EPMC6770816 | biostudies-literature
| S-EPMC7915613 | biostudies-literature
| S-EPMC5363199 | biostudies-literature
| S-EPMC11373645 | biostudies-literature
| S-EPMC5367378 | biostudies-literature
| PRJEB4408 | ENA
2017-05-24 | GSE89972 | GEO
2018-12-21 | GSE109513 | GEO